OTLKW NASDAQ
Outlook Therapeutics, Inc. - Se
1W: -12.0%
1M: -40.0%
3M: -82.9%
1Y: -97.0%
$0.03
Last traded 2022-02-16 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.01-0.035
Volume162,240
Avg Volume0
Beta0.00
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEONone
SectorHealthcare
IndustryBiotechnology
IPO Date2016-06-20
Latest News
Outlook Therapeutics Reports Second Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update
Outlook Therapeutics Announces Closing of $5.0 Million Registered Direct Offering
Outlook Therapeutics Announces Closing of $5.0 Million Public Offering
Outlook Therapeutics Announces Proposed Public Offering
Outlook Therapeutics Announces New $18.4 Million Non-Convertible Note Financing and Amendment to Existing Convertible Note
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Huang Andong | A-Award | 53,316 | $1.06 | 2025-10-03 |
| Haller Julia A | A-Award | 58,648 | $1.06 | 2025-10-03 |
| HILZINGER KURT J | A-Award | 90,638 | $1.06 | 2025-10-03 |
| Haddadin Yezan Munth | A-Award | 95,969 | $1.06 | 2025-10-03 |
| Auffarth Gerd | A-Award | 58,648 | $1.06 | 2025-10-03 |